You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Nicorandil reduced coronary events in stable angina

https://doi.org/10.1136/ebm.7.6.169

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Sources of funding: Merck Pharmaceuticals; Aventis Pharma; Chugai Pharmaceutical Company.

    • For correspondence: Professor H J Dargie, Western Infirmary, Glasgow, UK. Email h.dargie{at}bio.gla.ac.uk.

    • ↵* See glossary.